Clinical trial
Premenopausal Endocrine Responsive Chemotherapy Trial
NCT00066807 · ETOP IBCSG Partners Foundation, Other · Terminated
Key facts
| NCT number | NCT00066807 |
|---|---|
| Title | Premenopausal Endocrine Responsive Chemotherapy Trial |
| Official title | A Phase III Trial Evaluating the Role of Chemotherapy as Adjuvant Therapy for Premenopausal Women With Endocrine Responsive Breast Cancer Who Receive Endocrine Therapy |
| Acronym | PERCHE |
| Lead sponsor | ETOP IBCSG Partners Foundation, Other |
| Collaborators | National Cancer Institute (NCI) NIH Breast International Group |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Procedure |
| Interventions | chemotherapy, exemestane, tamoxifen, triptorelin, oophorectomy, ovarian irradiation |
| Enrollment | 29 |
| Start date | Aug 1, 2003 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Aug 7, 2003 |
| Last update posted | Oct 28, 2016 |
| Countries | Hungary, Italy, Switzerland |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: